Journal of Nuclear Cardiology

, Volume 15, Issue 5, pp 638–643 | Cite as

Prospective evaluation of the impact of diabetes and left ventricular hypertrophy on the relationship between ischemia and transient ischemic dilation of the left ventricle on single-day adenosine Tc-99m myocardial perfusion imaging

  • Louise Emmett
  • William J. Van Gaal
  • Michael Magee
  • Sarah Bass
  • Onn Ali
  • S. Ben Freedman
  • Hans Van der Wall
  • Leonard Kritharides
Original Articles


Background. Diabetes and left ventricular hypertrophy (LVH) can cause coronary flow reserve abnormalities in the absence of coronary artery disease (CAD). We sought to evaluate the impact of LVH and diabetes on the relationship between ischemia, severe CAD, and transient ischemic dilation (TID) on adenosine myocardial perfusion imaging (MPI).

Methods and Results. We prospectively recruited 157 patients referred for routine single-day adenosine technetium 99m MPI. LVH was assessed by use of transthoracic echocardiography. A ratio of 1.19 or greater on MPI defined TID in men and 1.31 or greater in women. Summed difference scores were determined by use of a 17-segment 5-point scoring system. TID was present in 22 of 157 patients (14%), diabetes in 54 of 157 (34%), and LVH in 42 of 157 (27%). By multivariate logistic regression, LVH, ischemia (summed difference score >2), and diabetes were independently predictive of TID. The incidence of TID was stratified by the presence or absence of diabetes and/or LVH in those with ischemia on MPI (8/8 [100%] vs 0/11 [0%], P<.002) or severe CAD on angiography (5/7 [71%] vs 0/8 [0%], P<.01). All those with TID (22/22 [100%]) had either diabetes or LVH (or both).

Conclusion. Although this study confirms the association between TID and both ischemia and severe CAD, all patients with TID had diabetes, LVH, or frequently, both, suggesting that the pathophysiology of these disease processes may play an integral role in the manifestation of TID on adenosine MPI.

Key Words

Transient ischemic dilation myocardial perfusion imaging left ventricular hypertrophy diabetes 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Iskandrian AS, Heo J, Nguyen T, Lyons E, Paugh E. Left ventricular dilatation and pulmonary thallium uptake after single-photon emission computer tomography using thallium-201 during adenosine-induced coronary hyperemia. Am J Cardiol 1990;66:807–11.PubMedCrossRefGoogle Scholar
  2. 2.
    Krawczynska EG, Weintraub WS, Garcia EV, Folks RD, Jones ME, Alazraki NP. Left ventricular dilatation and multivessel coronary artery disease on thallium-201 SPECT are important prognostic indicators in patients with large defects in the left anterior descending distribution. Am J Cardiol 1994;74:1233–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Mazzanti M, Germano G, Kiat H, Kavanagh PB, Alexanderson E, Friedman JD, et al. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol 1996;27:1612–20.PubMedCrossRefGoogle Scholar
  4. 4.
    McClellan JR, Travin MI, Herman SD, Baron JI, Golub RJ, Gallagher JJ, et al. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol 1997;79:600–5.PubMedCrossRefGoogle Scholar
  5. 5.
    McLaughlin MG, Danias PG. Transient ischemic dilation: A powerful diagnostic and prognostic finding of stress myocardial perfusion imaging. J Nucl Cardiol 2002;9:663–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Stolzenberg J. Dilatation of left ventricular cavity on stress thallium scan as an indicator of ischemic disease. Clin Nucl Med 1980;5:289–91.PubMedCrossRefGoogle Scholar
  7. 7.
    Takeishi Y, Tono-oka I, Ikeda K, Komatani A, Tsuiki K, Yasui S. Dilatation of the left ventricular cavity on dipyridamole thallium-201 imaging: A new marker of triple-vessel disease. Am Heart J 1991;121:466–75.PubMedCrossRefGoogle Scholar
  8. 8.
    Thomas GS, Miyamoto MI, Morello AP III, Majmundar H, Thomas JJ, Sampson CH, et al. Technetium 99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting. The Nuclear Utility in the Community (NUC) Study. J Am Coll Cardiol 2004;43:213–23.PubMedCrossRefGoogle Scholar
  9. 9.
    Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: A marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Emmett L, Magee M, Freedman SB, Van der Wall H, Bush V, Trieu J, et al. The role of left ventricular hypertrophy and diabetes in the presence of transient ischemic dilation of the left ventricle on myocardial perfusion SPECT images. J Nucl Med 2005;46:1596–601.PubMedGoogle Scholar
  11. 11.
    Di Carli MF, Afonso L, Campisi R, Ramappa P, Bianco-Batlles D, Grunberger G, et al. Coronary vascular dysfunction in premenopausal women with diabetes mellitus. Am Heart J 2002;144:711–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Di Carli MF, Bianco-Batlles D, Landa ME, Kazmers A, Groehn H, Muzik O, et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 1999;100:813–9.PubMedGoogle Scholar
  13. 13.
    Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003;41:1387–93.PubMedCrossRefGoogle Scholar
  14. 14.
    Kozakova M, Palombo C, Paterni M, Buralli S, Ciardetti M, Magagna A, et al. Myocardial perfusion response to dipyridamole in hypertensive left ventricular hypertrophy: A human study using myocardial contrast echocardiography. Microvasc Res 2002;64:482–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Romanens M, Gradel C, Saner H, Pfisterer M. Comparison of 99mTc-sestamibi lung/heart ratio, transient ischaemic dilation and perfusion defect size for the identification of severe and extensive coronary artery disease. Eur J Nucl Med 2001;28:907–10.PubMedCrossRefGoogle Scholar
  16. 16.
    Abidov A, Bax JJ, Hayes SW, Cohen I, Nishina H, Yoda S, et al. Integration of automatically measured transient ischemic dilation ratio into interpretation of adenosine stress myocardial perfusion SPECT for detection of severe and extensive CAD. J Nucl Med 2004;45:1999–2007.PubMedGoogle Scholar
  17. 17.
    Emmett L, Iwanochko RM, Freeman MR, Barolet A, Lee DS, Husain M. Reversible regional wall motion abnormalities on exercise technetium-99m-gated cardiac single photon emission computed tomography predict high-grade angiographic stenoses. J Am Coll Cardiol 2002;39:991–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Kakhki VR, Sadeghi R, Zakavi SR. Assessment of transient left ventricular dilation ratio via 2-day dipyridamole Tc-99m sestamibi nongated myocardial perfusion imaging. J Nucl Cardiol 2007;14:529–36.PubMedCrossRefGoogle Scholar
  19. 19.
    Rivero A, Santana C, Folks RD, Esteves F, Verdes L, Esiashvili S, et al. Attenuation correction reveals gender-related differences in the normal values of transient ischemic dilation index in restexercise stress sestamibi myocardial perfusion imaging. J Nucl Cardiol 2006;13:338–44.PubMedCrossRefGoogle Scholar
  20. 20.
    Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 2002;18:539–42.PubMedGoogle Scholar
  21. 21.
    Abidov A, Bax JJ, Hayes SW, Hachamovitch R, Cohen I, Gerlach J, et al. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol 2003;42:1818–25.PubMedCrossRefGoogle Scholar
  22. 22.
    Lette J, Lapointe J, Waters D, Cerino M, Picard M, Gagnon A. Transient left ventricular cavitary dilation during dipyridamole-thallium imaging as an indicator of severe coronary artery disease. Am J Cardiol 1990;66:1163–70.PubMedCrossRefGoogle Scholar
  23. 23.
    Meerdink DJ, Okada RD, Leppo JA. The effect of dipyridamole on transmural blood flow gradients. Chest 1989;96:400–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Van Tosh A, Hecht S, Berger M, Roberti R, Luna E, Horowitz SF. Exercise echocardiographic correlates of transient dilatation of the left ventricular cavity on exercise thallium-201 SPECT imaging. Chest 1994;106:1725–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Hansen CL, Sangrigoli R, Nkadi E, Kramer M. Comparison of pulmonary uptake with transient cavity dilation after exercise thallium-201 perfusion imaging. J Am Coll Cardiol 1999;33:1323–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Hung GU, Lee KW, Chen CP, Lin WY, Yang KT. Relationship of transient ischemic dilation in dipyridamole myocardial perfusion imaging and stress-induced changes of functional parameters evaluated by Tl-201 gated SPECT. J Nucl Cardiol 2005;12:268–75.PubMedCrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2003

Authors and Affiliations

  • Louise Emmett
    • 1
  • William J. Van Gaal
    • 1
  • Michael Magee
    • 1
  • Sarah Bass
    • 1
  • Onn Ali
    • 2
  • S. Ben Freedman
    • 2
  • Hans Van der Wall
    • 1
  • Leonard Kritharides
    • 2
  1. 1.From the Nuclear Medicine DepartmentaConcord Repatriation General Hospital, University of SydneySydneyAustralia
  2. 2.Cardiology DepartmentConcord Repatriation General Hospital, University of SydneySydneyAustralia

Personalised recommendations